228.12
0.52%
1.17
Handel nachbörslich:
228.12
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$226.95
Offen:
$226.33
24-Stunden-Volumen:
1.13M
Relative Volume:
0.72
Marktkapitalisierung:
$65.95B
Einnahmen:
$20.18B
Nettoeinkommen (Verlust:
$1.71B
KGV:
41.40
EPS:
5.51
Netto-Cashflow:
$3.07B
1W Leistung:
+1.92%
1M Leistung:
+1.73%
6M Leistung:
-1.51%
1J Leistung:
-6.24%
Becton Dickinson Co Stock (BDX) Company Profile
Firmenname
Becton Dickinson Co
Sektor
Telefon
(201) 847-6800
Adresse
ONE BECTON DR, FRANKLIN LAKES
Vergleichen Sie BDX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
228.12 | 65.95B | 20.18B | 1.71B | 3.07B | 5.94 |
ISRG
Intuitive Surgical Inc
|
538.83 | 191.92B | 7.87B | 2.24B | 586.00M | 6.22 |
ALC
Alcon Inc
|
86.30 | 42.68B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
233.88 | 34.33B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
333.43 | 24.15B | 2.88B | 499.60M | 321.60M | 6.74 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
2024-05-30 | Eingeleitet | Goldman | Buy |
2023-07-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
2023-05-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
2023-04-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2023-01-03 | Hochstufung | BofA Securities | Neutral → Buy |
2022-12-12 | Hochstufung | Citigroup | Sell → Neutral |
2022-07-11 | Herabstufung | Citigroup | Neutral → Sell |
2022-06-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-03-18 | Fortgesetzt | Raymond James | Mkt Perform |
2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
2021-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
2021-05-25 | Eingeleitet | Barclays | Equal Weight |
2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-07-09 | Hochstufung | Barclays | Equal Weight → Overweight |
2020-06-01 | Fortgesetzt | Goldman | Buy |
2020-03-05 | Eingeleitet | Citigroup | Neutral |
2020-02-07 | Herabstufung | Cowen | Outperform → Market Perform |
2020-02-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-02-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
2020-02-06 | Herabstufung | Cowen | Outperform → Market Perform |
2020-01-08 | Herabstufung | Barclays | Overweight → Equal Weight |
2019-05-13 | Hochstufung | Barclays | Equal Weight → Overweight |
2018-12-07 | Eingeleitet | Deutsche Bank | Buy |
2018-10-16 | Eingeleitet | Barclays | Equal Weight |
2018-06-21 | Hochstufung | JP Morgan | Neutral → Overweight |
2018-04-10 | Hochstufung | Citigroup | Neutral → Buy |
2018-01-19 | Fortgesetzt | BofA/Merrill | Buy |
2018-01-05 | Hochstufung | Citigroup | Sell → Neutral |
2018-01-05 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
2017-12-29 | Bestätigt | Deutsche Bank | Buy |
Alle ansehen
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Becton Dickinson & Co. stock rises Tuesday, still underperforms market - MarketWatch
Becton Dickinson EVP sells $633,810 in stock By Investing.com - Investing.com Australia
Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 Million Penalty, Express Fails To Disclose CEO's Full Compensation - Benzinga
Insider Selling: Becton, Dickinson and Company (NYSE:BDX) EVP Sells 2,838 Shares of Stock - MarketBeat
SEC charges Becton Dickinson with misleading investors about regulatory risks and product sales - JD Supra
Insider Sell: Michael Garrison Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus.com
BD receives FDA warning letter over quality system violations - MedTech Dive
Becton Dickinson EVP sells $633,810 in stock - Investing.com
Dominican Republic: A Strategic Destination Attracting Multimillion-Dollar Investments - GlobeNewswire Inc.
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
SEC Form DEFA14A filed by Becton Dickinson and Company - Quantisnow
Form DEF 14A BECTON DICKINSON & CO For: Dec 16 - StreetInsider.com
SEC Form DEF 14A filed by Becton Dickinson and Company - Quantisnow
Becton, Dickinson and Company (NYSE:BDX) Downgraded to Hold Rating by StockNews.com - MarketBeat
Becton Dickinson pays $175M for misleading investors about flawed IV pump system - Compliance Week
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing - Yahoo Finance
Here's Why Becton Dickinson (BDX) is a Strong Value Stock - Yahoo Finance
Becton Dickinson settles charges over infusion pump risks, SEC says - MSN
Becton, Dickinson and Company (NYSE:BDX) Short Interest Update - MarketBeat
BD settles SEC investigation into Alaris system for $175M - BioWorld Online
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Becton Dickinson's SWOT analysis: medical tech stock poised for growth - Investing.com
Becton Dickinson redundancy package agreed - Meath Chronicle
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Becton Dickinson to Pay $175 Million to Settle SEC Probe - Insurance Journal
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations - Marketscreener.com
BD Revolutionizes Blood Testing with Groundbreaking Finger-Prick Technology Partnership - StockTitan
BD to pay SEC $175M to settle Alaris investigation - Mass Device
Becton Dickinson To Pay SEC $175M Over Pump Claims - Law360
Becton, Dickinson to pay $175M to settle claims over misleading investors - Seeking Alpha
Becton Dickinson to Pay $175 Million Fine Related to SEC Investigation - Marketscreener.com
Becton Dickinson settles charges over infusion pump risks, SEC says By Reuters - Investing.com
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
SEC Punishes Becton Dickinson Over Misleading Alaris Pump Risks - Devdiscourse
BD Resolves Previously Disclosed SEC Investigation - Marketscreener.com
BD Resolves Previously Disclosed SEC Investigation – Company Announcement - Financial Times
Here’s Why Matrix Asset Advisors Added Becton, Dickinson and Company (BDX) - Yahoo Finance
Surgical Retractors Market Top PlayersMedtronic Plc, Becton, - openPR
Becton Dickinson (FRA:BOX) Enterprise Value : €79,407 Mil (As of Dec. 15, 2024) - GuruFocus.com
Franklin Resources Inc. Sells 365,924 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Shares Acquired by World Investment Advisors LLC - MarketBeat
Should Weakness in Becton, Dickinson and Company's (NYSE:BDX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo Finance
Becton, Dickinson and Company (NYSE:BDX) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Why Is Becton, Dickinson and Company (BDX) Among the Best Income Stocks to Buy According to Analysts? - Yahoo Finance
Becton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch
Tidal Investments LLC Grows Stake in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
BECTON DICKINSON : BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call - Marketscreener.com
BECTON DICKINSON : BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call - Marketscreener.com
Becton Dickinson : BD to Present at Investor Healthcare Conferences - Marketscreener.com
BECTON DICKINSON : BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call - Marketscreener.com
Finanzdaten der Becton Dickinson Co-Aktie (BDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):